1 Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A: Global cancer statistics 2018: Globocan estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: a cancer journal for clinicians 2018;68:394-424.
2 Khalaf N, El-Serag HB, Abrams HR, Thrift AP: Burden of pancreatic cancer: From epidemiology to practice. Clinical Gastroenterology Hepatology 2021;19:876-884.
3 Hruban RH, Gaida MM, Thompson E, Hong SM, Noë M, Brosens LA, Jongepier M, Offerhaus GJA, Wood LD: Why is pancreatic cancer so deadly? The pathologist's view. The Journal of pathology 2019;248:131-141.
4 Stewart BW, Kleihues P: World cancer report. 2003;
5 Yang Y-H, Liu J-B, Gui Y, Lei L-L, Zhang S-J: Relationship between autophagy and perineural invasion, clinicopathological features, and prognosis in pancreatic cancer. World journal of gastroenterology 2017;23:7232.
6 Gasparini G, Pellegatta M, Crippa S, Schiavo Lena M, Belfiori G, Doglioni C, Taveggia C, Falconi M: Nerves and pancreatic cancer: New insights into a dangerous relationship. Cancers 2019;11:893.
7 Liebig C, Ayala G, Wilks JA, Berger DH, Albo D: Perineural invasion in cancer: A review of the literature. Cancer: Interdisciplinary International Journal of the American Cancer Society 2009;115:3379-3391.
8 Nagakawa T, Kayahara M, Ueno K, Ohta T, Konishi I, Miyazaki I: Clinicopathological study on neural invasion to the extrapancreatic nerve plexus in pancreatic cancer. Hepato-gastroenterology 1992;39:51-55.
9 Huang C, Li Y, Guo Y, Zhang Z, Lian G, Chen Y, Li J, Su Y, Li J, Yang K: Mmp1/par1/sp/nk1r paracrine loop modulates early perineural invasion of pancreatic cancer cells. Theranostics 2018;8:3074.
10 Nan L, Qin T, Xiao Y, Qian W, Li J, Wang Z, Ma J, Ma Q, Wu Z: Pancreatic stellate cells facilitate perineural invasion of pancreatic cancer via hgf/c-met pathway. Cell transplantation 2019;28:1289-1298.
11 Muñoz M, Coveñas R: The neurokinin-1 receptor antagonist aprepitant, a new drug for the treatment of hematological malignancies: Focus on acute myeloid leukemia. Journal of Clinical Medicine 2020;9:1659.
12 Muñoz M, Coveñas R, Esteban F, Redondo M: The substance p/nk-1 receptor system: Nk-1 receptor antagonists as anti-cancer drugs. Journal of biosciences 2015;40:441-463.
13 Muñoz M, Coveñas R: Involvement of substance p and the nk-1 receptor in pancreatic cancer. World Journal Of Gastroenterology: WJG 2014;20:2321.
14 Johnson M, Young AD, Marriott I: The therapeutic potential of targeting substance p/nk-1r interactions in inflammatory cns disorders. Frontiers in cellular neuroscience 2017;10:296.
15 Chen X-Y, Ru G-Q, Ma Y-Y, Xie J, Chen W-Y, Wang H-J, Wang S-B, Li L, Jin K-T, He X-L: High expression of substance p and its receptor neurokinin-1 receptor in colorectal cancer is associated with tumor progression and prognosis. OncoTargets therapy 2016;9:3595.
16 Zheng S, Chen H, Wang Y, Gao W, Fu Z, Zhou Q, Jiang Y, Lin Q, Tan L, Ye H: Long non-coding rna loc389641 promotes progression of pancreatic ductal adenocarcinoma and increases cell invasion by regulating e-cadherin in a tnfrsf10a-related manner. Cancer letters 2016;371:354-365.
17 Wang J, Chen Y, Li X, Zou X: Perineural invasion and associated pain transmission in pancreatic cancer. Cancers 2021;13:4594.
18 Bakst RL, Glastonbury CM, Parvathaneni U, Katabi N, Hu KS, Yom SS: Perineural invasion and perineural tumor spread in head and neck cancer. International Journal of Radiation Oncology* Biology* Physics 2019;103:1109-1124.
19 Huang T, Fan Q, Wang Y, Cui Y, Wang Z, Yang L, Sun X, Wang Y: Schwann cell-derived ccl2 promotes the perineural invasion of cervical cancer. Frontiers in oncology 2020;10:19.
20 Kim CH, Yeom S-S, Lee SY, Kim HR, Kim YJ, Lee KH, Lee JH: Prognostic impact of perineural invasion in rectal cancer after neoadjuvant chemoradiotherapy. World journal of surgery 2019;43:260-272.
21 Lubig S, Thiesler T, Müller S, Vorreuther R, Leipner N, Kristiansen G: Quantitative perineural invasion is a prognostic marker in prostate cancer. Pathology 2018;50:298-304.
22 Ayala GE, Wheeler TM, Shine HD, Schmelz M, Frolov A, Chakraborty S, Rowley D: In vitro dorsal root ganglia and human prostate cell line interaction: Redefining perineural invasion in prostate cancer. The Prostate 2001;49:213-223.
23 Diemunsch P, Grélot L: Potential of substance p antagonists as antiemetics. Drugs 2000;60:533-546.
24 Muñoz M, González-Ortega A, Rosso M, Robles-Frias MJ, Carranza A, Salinas-Martín MV, Coveñas R: The substance p/neurokinin-1 receptor system in lung cancer: Focus on the antitumor action of neurokinin-1 receptor antagonists. Peptides 2012;38:318-325.
25 Munoz M, Rosso M, Covenas R, Montero I, González-Moles MA, Robles MJ: Neurokinin-1 receptors located in human retinoblastoma cell lines: Antitumor action of its antagonist, l-732,138. Investigative ophthalmology
visual science 2007;48:2775-2781.
26 Akazawa T, Kwatra SG, Goldsmith LE, Richardson MD, Cox EA, Sampson JH, Kwatra MM: A constitutively active form of neurokinin 1 receptor and neurokinin 1 receptor‐mediated apoptosis in glioblastomas. Journal of neurochemistry 2009;109:1079-1086.
27 Ebrahimi S, Javid H, Alaei A, Hashemy SI: New insight into the role of substance p/neurokinin‐1 receptor system in breast cancer progression and its crosstalk with micrornas. Clinical genetics 2020;98:322-330.
28 Friess H, Zhu Z, Liard V, Shi X, Shrikhande SV, Wang L, Lieb K, Korc M, Palma C, Zimmermann A: Neurokinin-1 receptor expression and its potential effects on tumor growth in human pancreatic cancer. Laboratory investigation 2003;83:731-742.
29 Deng XT, Tang SM, Wu PY, Li QP, Ge XX, Xu BM, Wang HS, Miao L: Sp/nk‐1r promotes gallbladder cancer cell proliferation and migration. Journal of cellular molecular medicine 2019;23:7961-7973.
30 Dong J, Feng F, Xu G, Zhang H, Hong L, Yang J: Elevated sp/nk-1r in esophageal carcinoma promotes esophageal carcinoma cell proliferation and migration. Gene 2015;560:205-210.
31 Brener S, González-Moles MA, Tostes D, Esteban F, Gil-Montoya JA, Ruiz-Avila I, Bravo M, Munoz M: A role for the substance p/nk-1 receptor complex in cell proliferation in oral squamous cell carcinoma. Anticancer research 2009;29:2323-2329.
32 Cook GA, Elliott D, Metwali A, Blum A, Sandor M, Lynch R, Weinstock J: Molecular evidence that granuloma t lymphocytes in murine schistosomiasis mansoni express an authentic substance p (nk-1) receptor. The Journal of Immunology 1994;152:1830-1835.
33 Walsh DT, Weg VB, Williams TJ, Nourshargh S: Substance p‐induced inflammatory responses in guinea‐pig skin: The effect of specific nk1 receptor antagonists and the role of endogenous mediators. British journal of pharmacology 1995;114:1343-1350.
34 Wang X, Deng Y, Mao Z, Ma X, Fan X, Cui L, Qu J, Xie D, Zhang J: Ccn1 promotes tumorigenicity through rac1/akt/nf-κb signaling pathway in pancreatic cancer. Tumor Biology 2012;33:1745-1758.
35 Zhang Y, Chen D, Zhang G, Wu X, Zhou L, Lin Y, Ding J, An F, Zhan QJOL: Microrna‑23b‑3p promotes pancreatic cancer cell tumorigenesis and metastasis via the jak/pi3k and akt/nf‑κb signaling pathways. 2020;20:1-1.
36 Chaudhary PM, Eby M, Jasmin A, Bookwalter A, Murray J, Hood L: Death receptor 5, a new member of the tnfr family, and dr4 induce fadd-dependent apoptosis and activate the nf-κb pathway. Immunity 1997;7:821-830.
37 Jeong S-J, Pise-Masison CA, Radonovich MF, Park HU, Brady JN: Activated akt regulates nf-κ b activation, p53 inhibition and cell survival in htlv-1-transformed cells. Oncogene 2005;24:6719-6728.